Martuza RL - Search Results

1

Enhanced antitumor efficacy of low-dose Etoposide with oncolytic herpes simplex virus in human glioblastoma stem cell xenografts.

Cheema TA, Kanai R, Kim GW, Wakimoto H, Passer B, Rabkin SD, Martuza RL. Cheema TA, et al. Among authors: martuza rl. Clin Cancer Res. 2011 Dec 1;17(23):7383-93. doi: 10.1158/1078-0432.CCR-11-1762. Epub 2011 Oct 5. Clin Cancer Res. 2011. PMID: 21976549 Free PMC article.

2

Systemic oncolytic herpes virus therapy of poorly immunogenic prostate cancer metastatic to lung.

Varghese S, Rabkin SD, Nielsen PG, Wang W, Martuza RL. Varghese S, et al. Among authors: martuza rl. Clin Cancer Res. 2006 May 1;12(9):2919-27. doi: 10.1158/1078-0432.CCR-05-1187. Clin Cancer Res. 2006. PMID: 16675589

3

Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy.

Liu TC, Zhang T, Fukuhara H, Kuroda T, Todo T, Martuza RL, Rabkin SD, Kurtz A. Liu TC, et al. Among authors: martuza rl. Mol Ther. 2006 Dec;14(6):789-97. doi: 10.1016/j.ymthe.2006.07.011. Epub 2006 Oct 10. Mol Ther. 2006. PMID: 17045531 Free article.

4

Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.

Kuroda T, Rabkin SD, Martuza RL. Kuroda T, et al. Among authors: martuza rl. Cancer Res. 2006 Oct 15;66(20):10127-35. doi: 10.1158/0008-5472.CAN-06-2744. Cancer Res. 2006. PMID: 17047077

5

Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.

Liu TC, Zhang T, Fukuhara H, Kuroda T, Todo T, Canron X, Bikfalvi A, Martuza RL, Kurtz A, Rabkin SD. Liu TC, et al. Among authors: martuza rl. Clin Cancer Res. 2006 Nov 15;12(22):6791-9. doi: 10.1158/1078-0432.CCR-06-0263. Clin Cancer Res. 2006. PMID: 17121900

6

Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide.

Aghi M, Rabkin SD, Martuza RL. Aghi M, et al. Among authors: martuza rl. Cancer Res. 2007 Jan 15;67(2):440-4. doi: 10.1158/0008-5472.CAN-06-3145. Cancer Res. 2007. PMID: 17234749

7

Oncolytic herpes simplex virus therapy for peripheral nerve tumors.

Jeyaretna DS, Rabkin SD, Martuza RL. Jeyaretna DS, et al. Among authors: martuza rl. Neurosurg Focus. 2007 Jun 15;22(6):E4. doi: 10.3171/foc.2007.22.6.5. Neurosurg Focus. 2007. PMID: 17613221 Review.

8

Herpes simplex virus Us3(-) mutant as oncolytic strategy and synergizes with phosphatidylinositol 3-kinase-Akt targeting molecular therapeutics.

Liu TC, Wakimoto H, Martuza RL, Rabkin SD. Liu TC, et al. Among authors: martuza rl. Clin Cancer Res. 2007 Oct 1;13(19):5897-902. doi: 10.1158/1078-0432.CCR-07-1013. Clin Cancer Res. 2007. PMID: 17908985

9

Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex viruses.

Varghese S, Rabkin SD, Nielsen GP, MacGarvey U, Liu R, Martuza RL. Varghese S, et al. Among authors: martuza rl. Cancer Res. 2007 Oct 1;67(19):9371-9. doi: 10.1158/0008-5472.CAN-07-0674. Cancer Res. 2007. PMID: 17909046

10

Trichostatin A and oncolytic HSV combination therapy shows enhanced antitumoral and antiangiogenic effects.

Liu TC, Castelo-Branco P, Rabkin SD, Martuza RL. Liu TC, et al. Among authors: martuza rl. Mol Ther. 2008 Jun;16(6):1041-7. doi: 10.1038/mt.2008.58. Epub 2008 Apr 1. Mol Ther. 2008. PMID: 18388912 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters